40 Participants NeededMy employer runs this trial

Triple Protein for Healthy Women

AS
Overseen ByAbbie Smith-Ryan
Age: 18 - 65
Sex: Female
Trial Phase: Academic
Sponsor: University of North Carolina, Chapel Hill

What You Need to Know Before You Apply

What is the purpose of this trial?

This single-site, randomized, blinded, placebo-controlled study will evaluate whether 4 weeks of daily Triple Support Protein powder improves glycemic control and overall well-being in healthy women aged 30-60 years. Participants will undergo baseline testing (DXA, fasting blood, standardized meal test with 2-hour glucose and insulin sampling), complete one acute supervised dose, and then consume a daily supplement for 4 weeks. During the final 14 days, participants will wear a continuous glucose monitor. Outcomes include postprandial glucose AUC, insulin sensitivity, and body composition.

Who Is on the Research Team?

AS

Abbie Smith-Ryan

Principal Investigator

University of North Carolina

Are You a Good Fit for This Trial?

Inclusion Criteria

Willing to abstain from caffeine, tobacco, and alcohol for 24 hours before testing days
I am a woman between 30 and 60 years old.
BMI 18.5-40 kg/m^2
See 2 more

Exclusion Criteria

Lactose intolerant
Currently supplementing whey protein
Severe hearing or speech impairment or inability to speak English
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline Testing

Participants undergo baseline testing including DXA, fasting blood, and standardized meal test with 2-hour glucose and insulin sampling

1 week
1 visit (in-person)

Treatment

Participants consume daily Triple Support Protein or placebo for 4 weeks, with weekly check-ins and continuous glucose monitoring during the final 14 days

4 weeks
4 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment, including end-of-study DXA and blood tests

2 weeks
1 visit (in-person)

What Are the Treatments Tested in This Trial?

Interventions

  • Triple Protein Support

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Placebo Group

Group I: Triple Protein SupportExperimental Treatment1 Intervention
Group II: PlaceboPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of North Carolina, Chapel Hill

Lead Sponsor

Trials
1,588
Recruited
4,364,000+

Perelel Inc.

Industry Sponsor

Trials
2
Recruited
100+